Charles River Laboratories International Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Thanks, everyone, for joining us. My name is Tejas Savant and I'm the Life Science Tools and Diagnostics Analyst at Morgan Stanley. Before we begin, I'd like to remind our listeners that important disclosure information can be found at morganstanley.com/research disclosures. So it's my pleasure today to host Charles River, and speaking on behalf of the company, we have Chairman, President and CEO, Jim Foster. Thank you for joining us today, Jim.
Questions & Answers
Maybe to just set the stage, let's start with the biopharma funding environment. You've called out sort of stable to improving trends here in the second quarter. It's something we've heard from other life science companies as well over the last couple of days. But then on the other hand, you've also talked about I guess, an inevitable normalization following a pretty unique multiyear period of R&D budget strength. Help us think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
